medical treatments

Novavax slashes sales guidance in half, stock plunges 34%

by

Novavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial expectations, sending shares down more than 30% in after-hours trading. Novavax NVAX, -5.01% now projects total 2022 revenue of $2 billion to $2.3 billion, after previously stating a goal of $4 billion to $5 billion. The U.S. Food and Drug … Read more

Stock Market Slides Because Russia Is Scarier Than the Federal Reserve

by

Text size Markets were poised to end the week higher, despite a hotter-than-hoped-for inflation reading on Thursday. Michael Nagle/Bloomberg It was like a splash of cold water to the face, but there’s reason to be optimistic about the stock market in the weeks and months ahead. The market was making headway this past week, shaking … Read more